Key facts
- This page summarizes Ofer Benyosef's Form 4 filing for ORMAT TECHNOLOGIES, INC. (ORA).
- 7 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Nov 2025, 21:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Disposed to Issuer
Options Exercise
Disposed to Issuer
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Represents the exercise of Stock Appreciation Rights ("SARs") expiring on 05/12/2026, for which the reporting person exercised all 21,271 shares.
Footnote F2
This represents the difference between the number of SARs exercised (21,271) and the number of shares issued as a result of the exercise (8,631). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($115.00) and the exercise price ($68.34).
Footnote F3
Represents the exercise of SARs expiring on 03/1/2028, for which the reporting person exercised 3,300 of the 4,401 shares.
Footnote F4
This represents the difference between the number of SARs exercised (3,300) and the number of shares issued as a result of the exercise (1,259). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($115.00) and the exercise price ($71.15).
Footnote F5
Represents shares of common stock sold in the open market on November 5, 2025 pursuant to a 10b5-1 Plan adopted by the reporting person on 06/26/2025.